If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

QuantumRD Services in China

1 Oct 2012 07:00

RNS Number : 5302N
ViaLogy PLC
01 October 2012
 



ViaLogy to Offer QuantumRD Services in China

 

 

London, UK October 1, 2012. ViaLogy PLC(LSE/AIM: VIY) announces that the company is in exploratory discussions with some of the largest Chinese national oil companies (NOCs) and upstream services providers to deploy QuantumRD® software platform for both their national and global assets.

 

As the world's 4th largest producer, China possesses substantial energy resources that include over 20 billion barrels of oil (14th largest in the world) and 100Tcf of natural gas. China's increasing energy needs coupled with growing emphasis on new discoveries, optimizing primary recovery efficiencies, and cost-effective development of proven fields provide a major opportunity for leveraging QuantumRD capabilities.

 

Some of the key strategic initiatives for Chinese operators include increasing production from mature fields; exploring new offshore areas of Bohai Bay and the South China Sea as well as onshore oil in western interior provinces such as Xinjiang and Inner Mongolia. QuantumRD processing to discover and characterize thin laminates, and delineate reservoirs below seismic resolution in complex tectonic stratigraphy using existing 3-D are seen as particularly attractive to support ongoing programs.

 

ViaLogy is discussing service delivery arrangements whereby QuantumRDsoftware platform can be utilized to determine the locations of new hydrocarbon assets on active fields. QuantumRD®can potentially provide more accurate structural and stratigraphic interpretations of seismic data than is now achievable with industry-standard tools. ViaLogy's software platform broadens the useable seismic spectra for both low and high frequencies, thus extracting porosity, lithology and fluid information from weak signal data normally discarded because it is buried in background noise and is unrecoverable. The technique is a major departure from current industry capabilities in reservoir characterization, and holds the promise of major cost avoidance and discovery of reserves otherwise undetected to increase the success rate of exploratory drilling and hydrocarbon recovery.

 

These business discussions follow issuance of a patent in China for QRI® related technology, which provides the fundamental weak signal processing and computational engine (employing quantum resonance interferometry) for ViaLogy's QuantumRD software platform. The company currently has a number of QuantumRD related patents pending in China.

ViaLogy CEO Robert Dean said, "We are excited by the possibility of applying QuantumRD technology on Chinese prospects, by the business value we could bring to their ongoing exploration and development efforts, and extending their de-risking toolkit for a wide range of conventional and non-conventional formations. We hope to provide the same increases in seismic resolution that we have shown to date with carbonate and sandstone reservoirs in the US and our offshore work in Asia."

Dean added, "We are currently in discussions with potential partners to find the best working structures and business models."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy/Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner Corporate Broking +44 (0) 20-7107-8000

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD® platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCWGUBABUPPGMU
Date   Source Headline
30th Nov 201511:20 amRNSNotice of Results
12th Nov 20157:00 amRNSPositive independent study results for IONA test
28th Oct 20157:00 amRNSAppointment to the Board
15th Oct 20153:56 pmRNSWorld first: in-house antenatal reflex screening
14th Oct 20157:00 amRNSClinical laboratory with expanded capacity opened
14th Oct 20157:00 amRNSHolding(s) in Company
13th Oct 20154:08 pmRNSResult of AGM
13th Oct 20152:20 pmRNSHolding(s) in Company
13th Oct 20157:01 amRNSAGM Statement
13th Oct 20157:00 amRNSPremaitha collaborates with Wolfson screening lab
12th Oct 20157:00 amRNSIndependent study of the IONA® test published
2nd Oct 20157:00 amRNSPremaitha appoints Greek distributor
1st Oct 20154:14 pmRNSPatent Infringement Proceedings Update
22nd Sep 20157:00 amRNSFinal Results
22nd Sep 20157:00 amRNSPremaitha signs contract for IONA test in Chile
15th Jul 20157:00 amRNSGrant of Options
13th Jul 20152:04 pmRNSHolding(s) in Company
6th Jul 20157:00 amRNSCQC accreditation for new NIPT lab
2nd Jul 20152:59 pmRNSCompletion of placing to raise £8 million
2nd Jul 20157:00 amRNSProposed placing to raise approximately £8 million
24th Jun 20157:00 amRNSNew IONA test clinical data showcased
22nd Jun 20157:00 amRNSNew contract for IONA® test
19th Jun 20157:00 amRNSTrading Update
4th Jun 20157:00 amRNSAppointment of Chief Financial Officer
5th May 20157:01 amRNSPremaitha Files Robust Defence with UK High Court
29th Apr 20151:53 pmRNSReissue of Options
31st Mar 20157:00 amRNSNew Contract for IONA test in Poland
23rd Mar 20159:53 amRNSLondon NHS trust teams up with Premaitha Health
16th Mar 20159:40 amRNSNotice of Patent Infringement Proceedings
16th Mar 20157:00 amRNSPremaitha Health signs first NIPT agreement
5th Feb 20157:00 amRNSCE Mark and Launch of the IONA test
30th Jan 20157:00 amRNSCommercial Launch Preparation Update
10th Dec 20147:00 amRNSResults for 7 months to 30 September 2014
25th Nov 20147:00 amRNSNotice of Half Year Results and IONA Test Showcase
4th Nov 201412:07 pmRNSResult of AGM
4th Nov 20147:00 amRNSAGM Statement
2nd Oct 20147:00 amRNSGrant of Options
30th Sep 20147:00 amRNSPublication of Annual Report and Notice of AGM
7th Jul 20144:47 pmRNSHolding(s) in Company
4th Jul 20144:28 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSFirst Day of Dealings on AIM
3rd Jul 20143:42 pmRNSChange of Name
3rd Jul 201411:36 amRNSResult of EGM
1st Jul 201410:47 amRNSOpen Offer Oversubcribed
13th Jun 20147:30 amRNSRestoration - ViaLogy Plc
13th Jun 20147:30 amRNSSchedule 1 - ViaLogy Plc
13th Jun 20147:00 amRNSPublication of Admission Document & Lifting of...
13th Jun 20147:00 amRNSDirectorate Change
13th Jun 20147:00 amRNSFinal Results
15th Apr 201412:30 pmRNSSuspension - Vialogy plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.